1. Solid lipid nanoparticles: a versatile approach for controlled release and targeted drug delivery.
- Author
-
Munir M, Zaman M, Waqar MA, Khan MA, and Alvi MN
- Subjects
- Humans, Drug Carriers chemistry, Drug Delivery Systems, Drug Liberation, Animals, Particle Size, Liposomes, Nanoparticles chemistry, Lipids chemistry, Delayed-Action Preparations chemistry
- Abstract
Solid Lipid Nanoparticles (SLN), the first type of lipid-based solid carrier systems in the nanometer range, were introduced as a replacement for liposomes. SLN are aqueous colloidal dispersions with solid biodegradable lipids as their matrix. SLN is produced using processes like solvent diffusion method and high-pressure homogenization, among others. Major benefits include regulated release, increased bioavailability, preservation of peptides and chemically labile compounds like retinol against degradation, cost-effective excipients, better drug integration, and a broad range of applications. Solid lipid nanoparticles can be administered via different routes, such as oral, parenteral, pulmonary, etc. SLN can be prepared by using high shear mixing as well as low shear mixing. The next generation of solid lipids, nanostructured lipid carriers (NLC), can reduce some of the drawbacks of SLN, such as its restricted capacity for drug loading and drug expulsion during storage. NLC are controlled nanostructured lipid particles that enhance drug loading. This review covers a brief introduction of solid lipid nanoparticles, manufacturing techniques, benefits, limitations, and their characterization tests.
- Published
- 2024
- Full Text
- View/download PDF